Extensive and severe CNS demyelination associated with golimumab therapy
- PMID: 27456211
- DOI: 10.1007/s00415-016-8238-5
Extensive and severe CNS demyelination associated with golimumab therapy
Similar articles
-
Rituximab in relapsing-remitting multiple sclerosis.N Engl J Med. 2008 Jun 12;358(24):2645; author reply 2646-7. N Engl J Med. 2008. PMID: 18557177 No abstract available.
-
[The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis].Ann Dermatol Venereol. 2011 May;138(5 Suppl 1):H11-5. doi: 10.1016/S0151-9638(11)70067-9. Ann Dermatol Venereol. 2011. PMID: 21703459 French. No abstract available.
-
Psoriatic arthritis - treatment update.Bull NYU Hosp Jt Dis. 2011;69(3):243-9. Bull NYU Hosp Jt Dis. 2011. PMID: 22035437 Review. No abstract available.
-
Drugs for rheumatoid arthritis.Treat Guidel Med Lett. 2012 May;10(117):37-44; quiz 2 p following 44. Treat Guidel Med Lett. 2012. PMID: 22538522 Review. No abstract available.
-
Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosis.J Neurol Sci. 2017 Sep 15;380:79-81. doi: 10.1016/j.jns.2017.07.014. Epub 2017 Jul 9. J Neurol Sci. 2017. PMID: 28870594
Cited by
-
CNS Demyelination with TNF-α Blockers.Curr Neurol Neurosci Rep. 2017 Apr;17(4):36. doi: 10.1007/s11910-017-0742-1. Curr Neurol Neurosci Rep. 2017. PMID: 28337644 Free PMC article. Review.
-
TNFα in MS and Its Animal Models: Implications for Chronic Pain in the Disease.Front Neurol. 2021 Dec 6;12:780876. doi: 10.3389/fneur.2021.780876. eCollection 2021. Front Neurol. 2021. PMID: 34938263 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources